Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Cleland

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Artificial Cardiac Pacing

Procedures

Geographic Areas

Europe

Devices

Implantable Defibrillators

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
84
Clark, Andrew
31
Nikitin, Nikolay
28
Witte, Klaus
27
Coletta, Alison
27
Komajda, Michel
23
Swedberg, Karl
20
Freemantle, Nick
19
Poole-Wilson, Philip
18
Rigby, Alan
17
Metra, Marco
17
Goode, Kevin
15
Follath, Ferenc
14
Thackray, Simon
14
Torp-Pedersen, Christian
11
Remme, Willem

Sign-in to see all Coauthors

Publications

TOP 3
Cleland John G F; McMurray John J V; Kjekshus John; Cornel Jan H; Dunselman Peter; Fonseca Cândida; Hjalmarson Ake; Korewicki Jerzy; Lindberg Magnus; Ranjith Naresh; van Veldhuisen Dirk J; Waagstein Finn; Wedel Hans; Wikstrand John;
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Clark Andrew L; Lammiman Michael J; Goode Kevin; Cleland John G F
Is taking part in clinical trials good for your health? A cohort study.
Berger Rudolf; Shankar Aparna; Fruhwald Friedrich; Fahrleitner-Pammer Astrid; Freemantle Nick; Tavazzi Luigi; Cleland John G F; Pacher Richard
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Cleland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Cleland John G F; McMurray John J V; Kjekshus John; Cornel Jan H; Dunselman Peter; Fonseca Cândida; Hjalmarson Ake; Korewicki Jerzy; Lindberg Magnus; Ranjith Naresh; van Veldhuisen Dirk J; Waagstein Finn; Wedel Hans; Wikstrand John;
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Journal of the American College of Cardiology 2009;54(20):1850-9.
2009: Clark Andrew L; Lammiman Michael J; Goode Kevin; Cleland John G F
Is taking part in clinical trials good for your health? A cohort study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(11):1078-83.
2009: Berger Rudolf; Shankar Aparna; Fruhwald Friedrich; Fahrleitner-Pammer Astrid; Freemantle Nick; Tavazzi Luigi; Cleland John G F; Pacher Richard
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.
European heart journal 2009;30(17):2109-16.
2009: Cleland John G F; Coletta Alison P; Torabi Azam; Clark Andrew L
Clinical trials update from the European Society of Cardiology heart failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(8):802-5.
2009: Ingle Lee; Isted Aaron; Witte Klaus K; Cleland John G F; Clark Andrew L
Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2009;16(4):451-6.
2009: Gervais Renaud; Leclercq Christophe; Shankar Aparna; Jacobs Sandra; Eiskjaer Hans; Johannessen Arne; Freemantle Nick; Cleland John G F; Tavazzi Luigi; Daubert Claude;
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(7):699-705.
2009: Cleland John G F; Coletta Alison P; Clark Andrew L; Cullington Damien
Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(6):622-30.
2009: Gheorghiade Mihai; Adams Kirkwood F; Cleland John G F; Cotter Gad; Felker G Michael; Filippatos Gerasimos S; Fonarow Gregg C; Greenberg Barry H; Hernandez Adrian F; Khan Sadiya; Komajda Michel; Konstam Marvin A; Liu Peter P; Maggioni Aldo P; Massie Barry M; McMurray John J; Mehra Mandeep; Metra Marco; O'Connell John; O'Connor Christopher M; Pang Peter S; Piña Ileana L; Sabbah Hani N; Teerlink John R; Udelson James E; Yancy Clyde W; Zannad Faiez; Stockbridge Norman;
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
American heart journal 2009;157(6):957-70.
2009: Cleland John G F; Swedberg Karl
Obituary to Philip Poole-Wilson 1943-2009.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(5):529.
2009: Farkas Jerneja; Nabb Samantha; Zaletel-Kragelj Lijana; Cleland John G F; Lainscak Mitja
Self-rated health and mortality in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(5):518-24.
2009: Ghio Stefano; Freemantle Nick; Scelsi Laura; Serio Alessandra; Magrini Giulia; Pasotti Michele; Shankar Aparna; Cleland John G F; Tavazzi Luigi
Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(5):480-8.
2009: Cohn Jay; Cleland John G F; Lubsen Jacobus; Borer Jeffrey S; Steg Philippe Gabriel; Perelman Michael; Zannad Faiez
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?
Journal of cardiac failure 2009;15(3):199-205.
2009: Zhang Jufen; Goode Kevin M; Cuddihy Paul E; Cleland John G F;
Predicting hospitalization due to worsening heart failure using daily weight measurement: analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(4):420-7.
2009: Kubánek Milos; Goode Kevin M; Lánská Vera; Clark Andrew L; Cleland John G F
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(4):367-77.
2009: Wikstrom Gerhard; Blomström-Lundqvist Carina; Andren Bertil; Lönnerholm Stefan; Blomström Per; Freemantle Nick; Remp Thomas; Cleland John G F;
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial.
European heart journal 2009;30(7):782-8.
2009: Cleland John G F; Cullington Damien
Digoxin: quo vadis?
Circulation. Heart failure 2009;2(2):81-5.
2009: Massie Barry M; Collins Joseph F; Ammon Susan E; Armstrong Paul W; Cleland John G F; Ezekowitz Michael; Jafri Syed M; Krol William F; O'Connor Christopher M; Schulman Kevin A; Teo Koon; Warren Stuart R;
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
Circulation 2009;119(12):1616-24.
2009: Cleland John G F; Calvert Melanie J; Verboven Yves; Freemantle Nick
Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study.
American heart journal 2009;157(3):457-66.
2009: Cleland John G F; Lewinter Christian; Goode Kevin M
Telemonitoring for heart failure: the only feasible option for good universal care?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(3):227-8.
2009: Wedel Hans; McMurray John J V; Lindberg Magnus; Wikstrand John; Cleland John G F; Cornel Jan H; Dunselman Peter; Hjalmarson Ake; Kjekshus John; Komajda Michel; Kuusi Timo; Vanhaecke Johan; Waagstein Finn;
Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(3):281-91.
2009: Levy Wayne C; Mozaffarian Dariush; Linker David T; Kenyon Kenneth W; Cleland John G F; Komajda Michel; Remme Willem J; Torp-Pedersen Christian; Metra Marco; Poole-Wilson Philip A;
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(3):256-63.
2009: Lainscak Mitja; Anker Stefan D; Cleland John G F
Smoking cessation in heart failure: easier said than done.
European heart journal 2009;30(5):624-5; author reply 625.
2009: Cleland John G F; Tavazzi Luigi; Daubert Jean-Claude; Tageldien Ahmed; Freemantle Nick
Cardiac resynchronization therapy: are modern myths preventing appropriate use?
Journal of the American College of Cardiology 2009;53(7):608-11.
2009: Coletta Alison P; Clark Andrew L; Cleland John G F
Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2009;11(2):214-9.
2008: Coletta Alison P; Cullington Damien; Clark Andrew L; Cleland John G F
Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(12):1264-7.
2008: Nieminen Markku S; Cleland John G F; Eha Jaan; Belenkov Yuri; Kivikko Matti; Põder Pentti; Sarapohja Toni
Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(12):1246-54.
2008: Cleland John G F; Cullington Damien; Khaleva Olga; Tageldien Ahmed
Cardiac resynchronization therapy: dyssynchrony imaging from a heart failure perspective.
Current opinion in cardiology 2008;23(6):634-45.
2008: Goode Kevin M; Clark Andrew L; Cleland John G F
Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
International journal of cardiology 2008;130(3):426-37.
2008: Uretsky Barry F; Thygesen Kristian; Daubert Jean-Claude; Erdmann Erland; Freemantle Nick; Gras Daniel; Kappenberger Lukas; Tavazzi Luigi; Cleland John G F
Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
Journal of cardiac failure 2008;14(8):670-5.
2008: Cleland John G F; Squire Iain; Ng Leong
Interpretation of amino-terminal pro-brain natriuretic peptide levels in the HPS and the CORONA study.
Journal of the American College of Cardiology 2008;52(13):1104-5.
2008: Maisel Alan; Mueller Christian; Adams Kirkwood; Anker Stefan D; Aspromonte Nadia; Cleland John G F; Cohen-Solal Alain; Dahlstrom Ulf; DeMaria Anthony; Di Somma Salvatore; Filippatos Gerasimos S; Fonarow Gregg C; Jourdain Patrick; Komajda Michel; Liu Peter P; McDonagh Theresa; McDonald Kenneth; Mebazaa Alexandre; Nieminen Markku S; Peacock W Frank; Tubaro Marco; Valle Roberto; Vanderhyden Marc; Yancy Clyde W; Zannad Faiez; Braunwald Eugene
State of the art: using natriuretic peptide levels in clinical practice.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(9):824-39.
2008: Coletta Alison P; Cleland John G F; Cullington Damien; Clark Andrew L
Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(9):917-20.
2008: Cleland John G F; Tageldien Ahmed; Maarouf Nidal; Hobson Neil
Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely.
Heart (British Cardiac Society) 2008;94(8):963-6.
2008: Pang Peter S; Tavares Miguel; Collins Sean P; Cleland John G F; Hollander Judd; Nieminen Markku; Miller Chadwick; Courtney D Mark; Kirk J Douglas; Masip Josep; Parkhomenko Alexander; Macarie Cezar; Peacock W Frank; Spinar Jindrich; Nowak Richard; Raev Dimitar; Storrow Alan B; Spisak Vladimir; Hamdy Ahmed; Mebazaa Alexandre; Gheorghiade Mihai;
Design and rationale of the URGENT Dyspnea study: an international, multicenter, prospective study.
American journal of therapeutics 2008;15(4):299-303.
2008: Rivero-Ayerza Maximo; Scholte Op Reimer Wilma; Lenzen Mattie; Theuns Dominic A M J; Jordaens Luc; Komajda Michel; Follath Ferenc; Swedberg Karl; Cleland John G F
New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey.
European heart journal 2008;29(13):1618-24.
2008: Clark Andrew L; Goode Kevin; Cleland John G F
The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(7):696-702.
2008: Murphy Jeremy J; Chakraborty Reena Roy; Fuat Ahmet; Davies Michael K; Cleland John G F
Diagnosis and management of patients with heart failure in England.
Clinical medicine (London, England) 2008;8(3):264-6.
2008: Goode Kevin M; Nabb Samantha; Cleland John G F; Clark Andrew L
A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic.
Journal of cardiac failure 2008;14(5):379-87.
2008: Cleland John G F; Coletta Alison P; Yassin Ashraf; Hado Hussien; Cullington Damien; Abdellah Ahmed Tageldien; Clark Andrew L
Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(6):614-20.
2008: Loh Poay Huan; Cleland John G F; Louis Amal A; Kennard Elizabeth D; Cook Jocelyn F; Caplin John L; Barsness Gregory W; Lawson William E; Soran Ozlem Z; Michaels Andrew D
Enhanced external counterpulsation in the treatment of chronic refractory angina: a long-term follow-up outcome from the International Enhanced External Counterpulsation Patient Registry.
Clinical cardiology 2008;31(4):159-64.
2008: Chattopadhyay Sudipta; Alamgir Mohammed F; Nikitin Nikolay P; Fraser Alan G; Clark Andrew L; Cleland John G F
The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(4):412-20.
2008: Torabi Azam; Cleland John G F; Khan Nasrin K; Loh Puan H; Clark Andrew L; Alamgir Farqad; Caplin John L; Rigby Alan S; Goode Kevin
The timing of development and subsequent clinical course of heart failure after a myocardial infarction.
European heart journal 2008;29(7):859-70.
2008: Pang Peter S; Cleland John G F; Teerlink John R; Collins Sean P; Lindsell Christopher J; Sopko George; Peacock W Frank; Fonarow Gregg C; Aldeen Amer Z; Kirk J Douglas; Storrow Alan B; Tavares Miguel; Mebazaa Alexandre; Roland Edmond; Massie Barry M; Maisel Alan S; Komajda Michel; Filippatos Gerasimos; Gheorghiade Mihai;
A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach.
European heart journal 2008;29(6):816-24.
2008: Cleland J G F; Freemantle N; Daubert J-C; Toff W D; Leisch F; Tavazzi L
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study.
Heart (British Cardiac Society) 2008;94(3):278-83.
2008: Lenzen M J; Rosengren A; Scholte op Reimer W J M; Follath F; Boersma E; Simoons M L; Cleland J G F; Komajda M
Management of patients with heart failure in clinical practice: differences between men and women.
Heart (British Cardiac Society) 2008;94(3):e10.
2008: Zannad Faiez; Stough Wendy Gattis; Pitt Bertram; Cleland John G F; Adams Kirkwood F; Geller Nancy L; Torp-Pedersen Christian; Kirwan Bridget-Anne; Follath Ferenc
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition.
European heart journal 2008;29(3):413-21.
2008: Nicol E D; Fittall B; Roughton M; Cleland J G F; Dargie H; Cowie M R
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland.
Heart (British Cardiac Society) 2008;94(2):172-7.
2008: Velavan Periaswamy; Loh Poay Huan; Clark Andrew; Cleland John G F
Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the answer to the cholesterol paradox in heart failure?
Congestive heart failure (Greenwich, Conn.) 2008;14(1):55.
2008: Cleland John G F; Coletta Alison P; Abdellah Ahmed Tageldien; Cullington Damien; Clark Andrew L; Rigby Alan S
Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(1):102-8.
2008: Ingle Lee; Witte Klaus K; Cleland John G F; Clark Andrew L
Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2008;10(1):85-8.
2008: Cleland John G F
POPADAD trial. Time for a proper study of aspirin after a vascular event?
BMJ (Clinical research ed.) 2008;337():a2583.
2007: Goode Kevin M; Clark Andrew L; Bristow Janet A; Sykes Kim B; Cleland John G F
Screening for left ventricular systolic dysfunction in high-risk patients in primary-care: a cost-benefit analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(12):1186-95.
2007: Velavan Periaswamy; Huan Loh Poay; Clark Andrew; Cleland John G F
The cholesterol paradox in heart failure.
Congestive heart failure (Greenwich, Conn.) 2007;13(6):336-41.
2007: McMurray John J V; Teerlink John R; Cotter Gadi; Bourge Robert C; Cleland John G F; Jondeau Guillaume; Krum Henry; Metra Marco; O'Connor Christopher M; Parker John D; Torre-Amione Guillermo; van Veldhuisen Dirk J; Lewsey Jim; Frey Aline; Rainisio Maurizio; Kobrin Isaac;
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;298(17):2009-19.
2007: Kjekshus John; Apetrei Eduard; Barrios Vivencio; Böhm Michael; Cleland John G F; Cornel Jan H; Dunselman Peter; Fonseca Cândida; Goudev Assen; Grande Peer; Gullestad Lars; Hjalmarson Ake; Hradec Jaromir; Jánosi András; Kamenský Gabriel; Komajda Michel; Korewicki Jerzy; Kuusi Timo; Mach François; Mareev Vyacheslav; McMurray John J V; Ranjith Naresh; Schaufelberger Maria; Vanhaecke Johan; van Veldhuisen Dirk J; Waagstein Finn; Wedel Hans; Wikstrand John;
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2007;357(22):2248-61.
2007: Mathur G; Cleland J G F; Rodrigues E; Davis G K
Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(11):1201-9.
2007: Lainscak Mitja; Cleland John G F; Lenzen Mattie J; Nabb Samantha; Keber Irena; Follath Ferenc; Komajda Michel; Swedberg Karl
Recall of lifestyle advice in patients recently hospitalised with heart failure: a EuroHeart Failure Survey analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(11):1095-103.
2007: Haworth J E; Moniz-Cook E; Clark A L; Wang M; Cleland J G F
An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population.
International journal of geriatric psychiatry 2007;22(11):1147-53.
2007: Damman Kevin; Navis Gerjan; Voors Adriaan A; Asselbergs Folkert W; Smilde Tom D J; Cleland John G F; van Veldhuisen Dirk J; Hillege Hans L
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
Journal of cardiac failure 2007;13(8):599-608.
2007: Bragadeesh Thanjavur K M; Mathur Gaurav; Clark Andrew L; Cleland John G F
Novel cardiac myosin activators for acute heart failure.
Expert opinion on investigational drugs 2007;16(10):1541-8.
2007: Cleland John G F; Abdellah Ahmed Tageldien; Khaleva Olga; Coletta Alison P; Clark Andrew L
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(10):1070-3.
2007: Cleland John G F; Atkin Stephen L
Thiazolidinediones, deadly sins, surrogates, and elephants.
Lancet 2007;370(9593):1103-4.
2007: van Veldhuisen Dirk J; Dickstein Kenneth; Cohen-Solal Alain; Lok Dirk J A; Wasserman Scott M; Baker Nigel; Rosser Dylan; Cleland John G F; Ponikowski Piotr
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
European heart journal 2007;28(18):2208-16.
2007: Metra Marco; Torp-Pedersen Christian; Cleland John G F; Di Lenarda Andrea; Komajda Michel; Remme Willem J; Dei Cas Livio; Spark Philip; Swedberg Karl; Poole-Wilson Philip A;
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(9):901-9.
2007: Cleland John G F; Taylor Jacqueline; Tendera Michal
Prognosis in heart failure with a normal ejection fraction.
The New England journal of medicine 2007;357(8):829-30.
2007: Olsson Lars G; Swedberg Karl; Cleland John G F; Spark Phillip A; Komajda Michel; Metra Marco; Torp-Pedersen Christian; Remme Willem J; Scherhag Armin; Poole-Wilson Philip;
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(8):795-801.
2007: Cleland John G F; Coletta Alison P; Abdellah Ahmed Tageldien; Witte Klaus K; Hobson Neil; Clark Andrew L
Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(8):850-3.
2007: Richardson Matthew; Freemantle Nick; Calvert Melanie J; Cleland John G F; Tavazzi Luigi;
Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial.
European heart journal 2007;28(15):1827-34.
2007: Torp-Pedersen Christian; Metra Marco; Charlesworth Andrew; Spark Phillip; Lukas Mary Ann; Poole-Wilson Philip A; Swedberg Karl; Cleland John G F; Di Lenarda Andrea; Remme Willem J; Scherhag Armin;
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET).
Heart (British Cardiac Society) 2007;93(8):968-73.
2007: de Silva Ramesh; Loh Huan; Rigby Alan S; Nikitin Nikolay P; Witte Klaus K A; Goode Kevin; Bhandari Sunil; Nicholson Anthony; Clark Andrew L; Cleland John G F
Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography.
The American journal of cardiology 2007;100(2):273-9.
2007: Mozaffarian Dariush; Anker Stefan D; Anand Inder; Linker David T; Sullivan Mark D; Cleland John G F; Carson Peter E; Maggioni Aldo P; Mann Douglas L; Pitt Bertram; Poole-Wilson Philip A; Levy Wayne C
Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
Circulation 2007;116(4):392-8.
2007: Gras D; Böcker D; Lunati M; Wellens H J J; Calvert M; Freemantle N; Gervais R; Kappenberger L; Tavazzi L; Erdmann E; Cleland J G F; Daubert J-C;
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(7):516-22.
2007: Fruhwald Friedrich M; Fahrleitner-Pammer Astrid; Berger Rudolf; Leyva Francisco; Freemantle Nick; Erdmann Erland; Gras Daniel; Kappenberger Lukas; Tavazzi Luigi; Daubert Jean-Claude; Cleland John G F
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
European heart journal 2007;28(13):1592-7.
2007: Torp-Pedersen Christian; Metra Marco; Spark Philip; Lukas Mary Ann; Moullet Christine; Scherhag Armin; Komajda Michel; Cleland John G F; Remme Willem; Di Lenarda Andrea; Swedberg Karl; Poole-Wilson Philip A;
The safety of amiodarone in patients with heart failure.
Journal of cardiac failure 2007;13(5):340-5.
2007: Windram Jonathan D; Loh Puan H; Rigby Alan S; Hanning Ian; Clark Andrew L; Cleland John G F
Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
American heart journal 2007;153(6):1048-55.
2007: Cleland John G F; Coletta Alison P; Clark Andrew L
Clinical trials update from the American College of Cardiology 2007: ALPHA, EVEREST, FUSION II, VALIDD, PARR-2, REMODEL, SPICE, COURAGE, COACH, REMADHE, pro-BNP for the evaluation of dyspnoea and THIS-diet.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(6-7):740-5.
2007: Cleland John G F; Shelton Rhiddian; Nikitin Nikolay; Ford Sarah; Frison Lars; Grind Margaretha
Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(6-7):730-9.
2007: Komajda Michel; Hanon Olivier; Hochadel Matthias; Follath Ferenc; Swedberg Karl; Gitt Anselm; Cleland John G F
Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I.
European heart journal 2007;28(11):1310-8.
2007: Ingle Lee; Goode Kevin; Carroll Sean; Sloan Rebecca; Boyes Carrie; Cleland John G F; Clark Andrew L
Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure.
International journal of cardiology 2007;118(3):350-5.
2007: Clark Robyn A; Inglis Sally C; McAlister Finlay A; Cleland John G F; Stewart Simon
Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2007;334(7600):942.
2007: Khan Nasrin K; Goode Kevin M; Cleland John G F; Rigby Alan S; Freemantle Nick; Eastaugh Joanne; Clark Andrew L; de Silva Ramesh; Calvert Melanie J; Swedberg Karl; Komajda Michael; Mareev Viu; Follath Ferenc;
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(5):491-501.
2007: Huan Loh Poay; Windram Jonathan D; Tin Lwin; Reddy Priya; Velavan Periaswamy; Rigby Alan S; Atkin Paul; Nikitin Nikolay P; Clark Andrew L; Cleland John G F
The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction.
American heart journal 2007;153(4):537-44.
2007: de Silva Ramesh; Nikitin Nikolay P; Witte Klaus K A; Rigby Alan S; Loh Huan; Nicholson Anthony; Bhandari Sunil; Clark Andrew L; Cleland John G F
Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(4):415-23.
2007: Lainscak Mitja; Cleland John G F; Lenzen Mattie J; Keber Irena; Goode Kevin; Follath Ferenc; Komajda Michel; Swedberg Karl
Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey.
The American journal of cardiology 2007;99(6B):31D-37D.
2007: Remme Willem J; Torp-Pedersen Christian; Cleland John G F; Poole-Wilson Philip A; Metra Marco; Komajda Michel; Swedberg Karl; Di Lenarda Andrea; Spark Phillip; Scherhag Armin; Moullet Christine; Lukas Mary Ann
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.
Journal of the American College of Cardiology 2007;49(9):963-71.
2007: Hoppe Uta C; Freemantle Nick; Cleland John G F; Marijianowski Monique; Erdmann Erland
Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure.
Diabetes care 2007;30(3):722-4.
2007: Lainscak Mitja; Cleland John G F; Lenzen Mattie J; Follath Ferenc; Komajda Michel; Swedberg Karl
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(3):292-9.
2007: Cleland John G F; Nasir Mansour; Tageldien Ahmed
Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
Nature clinical practice. Cardiovascular medicine 2007;4(2):90-101.
2007: Shelton R J; Goode K; Cleland J G
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(2):147; author reply 148.
2007: Cleland John G F; Coletta Alison P; Abdellah Ahmed Tageldien; Nasir Mansoor; Hobson Neil; Freemantle Nick; Clark Andrew L
Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2007;9(1):92-7.
2007: Yao Guiqing; Freemantle Nick; Calvert Melanie J; Bryan Stirling; Daubert Jean-Claude; Cleland John G F
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
European heart journal 2007;28(1):42-51.
2006: Cleland John G F; Velavan Periaswamy; Nasir Mansour
Fighting against sudden death: a single or multidisciplinary approach.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2006;17(3):205-10.
2006: Cleland John G F; Coletta Alison; Witte Klaus
Practical applications of intravenous diuretic therapy in decompensated heart failure.
The American journal of medicine 2006;119(12 Suppl 1):S26-36.
2006: Cleland John G F; Coletta Alison P; Clark Andrew L
Clinical trials update from the Heart Failure Society of America meeting: FIX-CHF-4, selective cardiac myosin activator and OPT-CHF.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(7):764-6.
2006: Khand Aleem U; Rankin Andrew C; Cleland John G F; Gemmell Islay; Clark Elaine; Macfarlane Peter W
The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(11):927-34.
2006: Cleland John G F; Coletta Alison P; Clark Andrew L
Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(6):658-61.
2006: Thackray Simon D R; Ghosh Justin M; Wright Graham A; Witte Klaus K A; Nikitin Nikolay P; Kaye Gerald C; Clark Andrew L; Tweddel Ann; Cleland John G F
The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers.
American heart journal 2006;152(4):713.e9-13.
2006: Cleland John G F; Tendera Michal; Adamus Jerzy; Freemantle Nick; Polonski Lech; Taylor Jacqueline;
The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
European heart journal 2006;27(19):2338-45.
2006: Shelton Rhidian J; Clark Andrew L; Goode Kevin; Rigby Alan S; Cleland John G F
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation.
European heart journal 2006;27(19):2353-61.
2006: Nikitin Nikolay P; Constantin Cristina; Loh Poay Huan; Ghosh Justin; Lukaschuk Elena I; Bennett Anna; Hurren Sarah; Alamgir Farqad; Clark Andrew L; Cleland John G F
New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2006;7(5):365-72.
2006: Witte K K A; Nikitin N P; Cleland J G F; Clark A L
Excessive breathlessness in patients with diastolic heart failure.
Heart (British Cardiac Society) 2006;92(10):1425-9.
2006: Ghio Stefano; Freemantle Nick; Serio Alessandra; Magrini Giulia; Scelsi Laura; Pasotti Michele; Cleland John G F; Tavazzi Luigi
Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2006;7(5):373-8.
2006: Coletta Alison P; Tin Lwin; Loh P Huan; Clark Andrew L; Cleland John G F
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(5):547-9.
2006: de Silva Ramesh; Rigby Alan S; Witte Klaus K A; Nikitin Nikolay P; Tin Lwin; Goode Kevin; Bhandari Sunil; Clark Andrew L; Cleland John G F
Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.
The American journal of cardiology 2006;98(3):391-8.
2006: Cleland John G F; Daubert Jean-Claude; Erdmann Erland; Freemantle Nick; Gras Daniel; Kappenberger Lukas; Tavazzi Luigi
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
European heart journal 2006;27(16):1928-32.
2006: Thackray Simon D R; Wright Graham A; Witte Klaus K A; Nikitin Nikolay P; Tweddel Ann C; Clark Andrew L; Cleland John G F
The effect of ventricular pacing on measurements of left ventricular function: a comparison between echocardiographic methods and with radionuclide ventriculography.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2006;7(4):284-92.
2006: Hoppe Uta C; Casares Jaime M; Eiskjaer Hans; Hagemann Arne; Cleland John G F; Freemantle Nick; Erdmann Erland
Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
Circulation 2006;114(1):18-25.
2006: Komajda Michel; Anker Stefan D; Charlesworth Andrew; Okonko Darlington; Metra Marco; Di Lenarda Andrea; Remme Willem; Moullet Christine; Swedberg Karl; Cleland John G F; Poole-Wilson Philip A
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
European heart journal 2006;27(12):1440-6.
2006: Freemantle N; Tharmanathan P; Calvert M J; Abraham W T; Ghosh J; Cleland J G F
Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction -- a systematic review and meta-analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(4):433-40.
2006: Prasad S K; Dargie H J; Smith G C; Barlow M M; Grothues F; Groenning B A; Cleland J G F; Pennell D J
Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.
Heart (British Cardiac Society) 2006;92(6):798-803.
2006: Nikitin N P; Loh P H; Silva R de; Ghosh J; Khaleva O Y; Goode K; Rigby A S; Alamgir F; Clark A L; Cleland J G F
Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.
Heart (British Cardiac Society) 2006;92(6):775-9.
2006: Ekman Inger; Andersson Gull; Boman Kurt; Charlesworth Andrew; Cleland John G F; Poole-Wilson Philip; Swedberg Karl
Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial.
Patient education and counseling 2006;61(3):348-53.
2006: Cleland John G F; Coletta Alison P; Nikitin Nikolay P; Clark Andrew L
Clinical trials update from the American College of Cardiology: Darbepoetin alfa, ASTEROID, UNIVERSE, paediatric carvedilol, UNLOAD and ICELAND.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(3):326-9.
2006: Ingle Lee; Reddy Priya; Clark Andrew L; Cleland John G F
Diabetes lowers six-minute walk test performance in heart failure.
Journal of the American College of Cardiology 2006;47(9):1909-10.
2006: Cleland John G F
Chronic aspirin therapy for the prevention of cardiovascular events: a waste of time, or worse?
Nature clinical practice. Cardiovascular medicine 2006;3(5):234-5.
2006: Ingle L; Rigby A S; Nabb S; Jones P K; Clark A L; Cleland J G F
Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(3):321-5.
2006: Cleland John G F; Charlesworth Andrew; Lubsen Jacobus; Swedberg Karl; Remme Willem J; Erhardt Leif; Di Lenarda Andrea; Komajda Michel; Metra Marco; Torp-Pedersen Christian; Poole-Wilson Philip A;
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
Journal of the American College of Cardiology 2006;47(8):1603-11.
2006: Metra Marco; Dei Cas Livio; Cleland John G F
Pharmacokinetic and pharmacodynamic characteristics of beta-blockers: when differences may matter.
Journal of cardiac failure 2006;12(3):177-81.
2006: Witte K K A; Cleland J G F; Clark A L
Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.
Heart (British Cardiac Society) 2006;92(4):481-6.
2006: Nikitin Nikolay P; Loh Poay Huan; de Silva Ramesh; Witte Klaus K A; Lukaschuk Elena I; Parker Anita; Farnsworth T Alan; Alamgir Farqad M; Clark Andrew L; Cleland John G F
Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study.
International journal of cardiology 2006;108(1):76-83.
2006: Cleland John G F; Loh Huan; Windram Jonathan; Goode Kevin; Clark Andrew L
Threats, opportunities, and statins in the modern management of heart failure.
European heart journal 2006;27(6):641-3.
2006: Loh P H; Louis A A; Windram J; Rigby A S; Cook J; Hurren S; Nikolay N P; Caplin J; Cleland J G F
The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina.
Journal of internal medicine 2006;259(3):276-84.
2006: de Silva Ramesh; Nikitin Nikolay P; Witte Klaus K A; Rigby Alan S; Goode Kevin; Bhandari Sunil; Clark Andrew L; Cleland John G F
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis.
European heart journal 2006;27(5):569-81.
2006: Ingle L; Goode K; Rigby A S R; Cleland J G F; Clark A L
Predicting peak oxygen uptake from 6-min walk test performance in male patients with left ventricular systolic dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(2):198-202.
2006: Shelton R J; Rigby A S; Cleland J G F; Clark A L
Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure.
Heart (British Cardiac Society) 2006;92(3):331-6.
2006: Velavan P; Khan N K; Rigby A S; Goode K; Komajda M; Follath F; Swedberg K; Madeira H; Clark A L; Cleland J G F
Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey.
Heart (British Cardiac Society) 2006;92(2):255-6.
2006: Cleland John G F; Goode Kevin; Khaleva Olga; Khan Nasrin
How many patients need cardiac resynchronization therapy?
European heart journal 2006;27(3):251-2.
2006: Thackray Simon D R; Witte Klaus; Ghosh Justin; Nikitin Nikolay; Anderson Anne; Rigby Alan; Goode Kevin; Clark Andrew L; Cleland John G F
N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population.
European heart journal 2006;27(4):447-53.
2006: Cleland John G F; Freemantle Nick; Coletta Alison P; Clark Andrew L
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(1):105-10.
2006: Sample Jessica; Cleland John G F; Seymour Anne-Marie L
Metabolic remodeling in the aging heart.
Journal of molecular and cellular cardiology 2006;40(1):56-63.
2005: Calvert Melanie J; Freemantle Nick; Yao Guiqing; Cleland John G F; Billingham Lucinda; Daubert Jean-Claude; Bryan Stirling;
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
European heart journal 2005;26(24):2681-8.
2005: Lenzen Mattie J; Boersma Eric; Reimer Wilma J M Scholte Op; Balk Aggie H M M; Komajda Michel; Swedberg Karl; Follath Ferenc; Jimenez-Navarro Manuel; Simoons Maarten L; Cleland John G F
Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
European heart journal 2005;26(24):2706-13.
2005: Witte Klaus K A; Nikitin Nikolay P; Parker Anita C; von Haehling Stephan; Volk Hans-Dieter; Anker Stefan D; Clark Andrew L; Cleland John G F
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
European heart journal 2005;26(21):2238-44.
2005: Metra Marco; Torp-Pedersen Christian; Swedberg Karl; Cleland John G F; Di Lenarda Andrea; Komajda Michel; Remme Willem J; Lutiger Beatrix; Scherhag Armin; Lukas Mary Ann; Charlesworth Andrew; Poole-Wilson Philip A
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
European heart journal 2005;26(21):2259-68.
2005: Ingle Lee; Shelton Rhidian J; Cleland John G F; Clark Andrew L
Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure.
Journal of cardiac failure 2005;11(8):619-23.
2005: Cleland John G F; Coletta Alison P; Lammiman Mike; Witte Klaus K; Loh Huan; Nasir Mansoor; Clark Andrew L
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(6):1070-5.
2005: Witte Klaus K A; Thackray Simon D R; Lindsay Kenneth A; Cleland John G F; Clark Andrew L
Metabolic gas kinetics depend upon the level of exercise performed.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(6):991-6.
2005: Clark Andrew L; Cleland John G F
Anemia and chronic heart failure: are we asking the right questions?
Circulation 2005;112(12):1681-3.
2005: Radford Martha J; Arnold J Malcolm O; Bennett Susan J; Cinquegrani Michael P; Cleland John G F; Havranek Edward P; Heidenreich Paul A; Rutherford John D; Spertus John A; Stevenson Lynne Warner; Goff David C; Grover Frederick L; Malenka David J; Peterson Eric D; Redberg Rita F;
ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America.
Circulation 2005;112(12):1888-916.
2005: Ingle Lee; Shelton Rhidian J; Rigby Alan S; Nabb Samantha; Clark Andrew L; Cleland John G F
The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure.
European heart journal 2005;26(17):1742-51.
2005: Cleland John G F; Coletta Alison P; Freemantle Nick; Velavan Periaswamy; Tin Lwin; Clark Andrew L
Clinical trials update from the American College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):931-6.
2005: Ekman Inger; Cleland John G F; Andersson Bert; Swedberg Karl
Exploring symptoms in chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):699-703.
2005: Khand Aleem U; Shaw Morag; Gemmel Islay; Cleland John G F
Do discharge codes underestimate hospitalisation due to heart failure? Validation study of hospital discharge coding for heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):792-7.
2005: Haworth J E; Moniz-Cook E; Clark A L; Wang M; Waddington R; Cleland J G F
Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):803-8.
2005: Cleland John G F; Coletta Alison P; Clark Andrew L; Velavan Periaswamy; Ingle Lee
Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):937-9.
2005: Cleland John G F; Sullivan John T; Ball Stephen; Horowitz John D; Agoram Balaji; Rosser Dylan; Yates Wayne; Tin Lwin; Fuentealba Paulina; Burton Paul B J
Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation.
Journal of cardiovascular pharmacology 2005;46(2):155-61.
2005: Hobbs F D Richard; Korewicki Jerzy; Cleland John G F; Eastaugh Joanne; Freemantle Nick;
The diagnosis of heart failure in European primary care: The IMPROVEMENT Programme survey of perception and practice.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(5):768-79.
2005: de Silva Ramesh; Nikitin Nikolay P; Bhandari Sunil; Nicholson Anthony; Clark Andrew L; Cleland John G F
Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
European heart journal 2005;26(16):1596-605.
2005: Teerlink John R; McMurray John J V; Bourge Robert C; Cleland John G F; Cotter Gadi; Jondeau Guillaume; Krum Henry; Metra Marco; O'Connor Christopher M; Parker John D; Torre-Amione Guillermo; Van Veldhuisen Dirk J; Frey Aline; Rainisio Maurizio; Kobrin Isaac;
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
American heart journal 2005;150(1):46-53.
2005: Orn Stein; Cleland John G F; Romo Matti; Kjekshus John; Dickstein Kenneth
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.
The American journal of medicine 2005;118(7):752-8.
2005: Clark A L; Cleland J G F
Multidisciplinary interventions in heart failure.
Heart (British Cardiac Society) 2005;91(7):849-50.
2005: Nikitin Nikolay P; Witte Klaus K A; Ingle Lee; Clark Andrew L; Farnsworth T Alan; Cleland John G F
Longitudinal myocardial dysfunction in healthy older subjects as a manifestation of cardiac ageing.
Age and ageing 2005;34(4):343-9.
2005: Clark Andrew L; Cleland John G F
Beta-blockers, exercise, and ventilation in chronic heart failure.
Journal of cardiac failure 2005;11(5):340-2.
2005: Di Lenarda Andrea; Remme Willem J; Charlesworth Andrew; Cleland John G F; Lutiger Beatrix; Metra Marco; Komajda Michel; Torp-Pedersen Christian; Scherhag Armin; Swedberg Karl; Poole-Wilson Philip A;
Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(4):640-9.
2005: Witte Klaus K A; Thackray Simon; Nikitin Nikolay P; Cleland John G F; Clark Andrew L
The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(4):612-7.
2005: Cleland John G F; Louis Amala A; Rigby Alan S; Janssens Uwe; Balk Aggie H M M;
Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
Journal of the American College of Cardiology 2005;45(10):1654-64.
2005: Ekman Inger; Cleland John G F; Swedberg Karl; Charlesworth Andrew; Metra Marco; Poole-Wilson Philip A
Symptoms in patients with heart failure are prognostic predictors: insights from COMET.
Journal of cardiac failure 2005;11(4):288-92.
2005: Cleland J G F; Torabi A; Khan N K
Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.
Heart (British Cardiac Society) 2005;91 Suppl 2():ii7-13; discussion ii31, ii43-8.
2005: Cleland John G F; Loh Huan; Windram Jonathan
Are there clinically important differences between beta-blockers in heart failure?
Heart failure clinics 2005;1(1):57-66.
2005: Olsson Lars G; Swedberg Karl; Clark Andrew L; Witte Klaus K; Cleland John G F
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.
European heart journal 2005;26(8):778-93.
2005: Cleland John G F; Daubert Jean-Claude; Erdmann Erland; Freemantle Nick; Gras Daniel; Kappenberger Lukas; Tavazzi Luigi;
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
The New England journal of medicine 2005;352(15):1539-49.
2005: Calvert Melanie J; Freemantle Nick; Cleland John G F
The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(2):243-51.
2005: Cleland J G F; Daubert J C; Erdmann E; Freemantle N; Gras D; Kappenberger L; Klein W; Tavazzi L;
Baseline characteristics of patients recruited into the CARE-HF study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(2):205-14.
2005: Torp-Pedersen Christian; Poole-Wilson Philip A; Swedberg Karl; Cleland John G F; Di Lenarda Andrea; Hanrath Peter; Komajda Michel; Lutiger Beatrix; Metra Marco; Remme Willem J; Scherhag Armin; Skene Allan;
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
American heart journal 2005;149(2):370-6.
2005: Calvert Melanie; Freemantle Nick; Cleland John G F
Cardiac resynchronization therapy in heart failure.
Annals of internal medicine 2005;142(4):305-7; author reply 307-8.
2005: Cleland John G F
Patients with treatable malignant diseases--including heart failure--are entitled to specialist care.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(2):207-9.
2005: Shelton Rhidian J; Velavan Periaswamy; Nikitin Nikolay P; Coletta Alison P; Clark Andrew L; Rigby Alan S; Freemantle Nick; Cleland John G F;
Clinical trials update from the American Heart Association meeting: ACORN-CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A-HeFT, GEMINI, vitamin E meta-analysis, ESCAPE, CARP, and SCD-HeFT cost-effectiveness study.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(1):127-35.
2005: Cowburn Peter J; Cleland John G F; McDonagh Theresa A; McArthur John D; Dargie Henry J; Morton James J
Comparison of selective ET(A) and ET(B) receptor antagonists in patients with chronic heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2005;7(1):37-42.
2004: Cleland J G F; Loh H; Windram J
Some current controversies in heart failure (2004-2005).
Minerva cardioangiologica 2004;52(6):465-77.
2004: Lalukota Krishna; Cleland John G F; Ingle Lee; Clark Andrew L; Coletta Alison P
Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(7):953-5.
2004: Cleland John G F; Ghosh Justin; Freemantle Nick
Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?
Nature clinical practice. Cardiovascular medicine 2004;1(1):10-1.
2004: Cleland John G F; Huan Loh P; Freemantle Nick; Clark Andrew L; Coletta Alison P
Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(6):787-91.
2004: Nikitin N P; de Silva R; Cleland J G F
The utility of a comprehensive cardiac magnetic resonance examination for the evaluation of patients with heart failure.
Heart (British Cardiac Society) 2004;90(10):1166.
2004: Witte K K A; Nikitin N P; De Silva R; Cleland J G F; Clark A L
Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure.
Heart (British Cardiac Society) 2004;90(10):1144-50.
2004: Coletta Alison P; Cleland John G F; Freemantle Nick; Clark Andrew L
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(5):673-6.
2004: Cleland John G F
Comprehensive adrenergic receptor blockade with carvedilol is superior to beta-1-selective blockade with metoprolol in patients with heart failure: COMET.
Current heart failure reports 2004;1(2):82-8.
2004: Cleland J G F; Findlay I; Jafri S; Sutton G; Falk R; Bulpitt C; Prentice C; Ford I; Trainer Adele; Poole-Wilson P A
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.
American heart journal 2004;148(1):157-64.
2004: Bellenger N G; Rajappan K; Rahman S L; Lahiri A; Raval U; Webster J; Murray G D; Coats A J S; Cleland J G F; Pennell D J;
Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
Heart (British Cardiac Society) 2004;90(7):760-4.
2004: Cleland John G F; Ghosh Justin; Freemantle Nick; Kaye Gerry C; Nasir Mansoor; Clark Andrew L; Coletta Alison P
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(4):501-8.
2004: Banerjee Prithwish; Clark Andrew L; Nikitin Nikolay; Cleland John G F
Diastolic heart failure. Paroxysmal or chronic?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(4):427-31.
2004: Witte Klaus K A; Desilva Ramesh; Chattopadhyay Sudipta; Ghosh Justin; Cleland John G F; Clark Andrew L
Are hematinic deficiencies the cause of anemia in chronic heart failure?
American heart journal 2004;147(5):924-30.
2004: Witte Klaus K A; Morice Alyn; Cleland John G F; Clark Andrew L
The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry.
Journal of cardiac failure 2004;10(2):149-54.
2004: Cleland John G F; Goode Kevin; Erhardt Leif; Remme Willem J; Charlesworth Andrew; Poole-Wilson Philip A; Di Lenarda Andrea; Hanrath Peter; Komajda Michel; Metra Marco; Swedberg Karl; Torp-Pedersen Christian;
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(2):139-52.
2004: Shelton R J; Kaye G C; Cleland J G F
Controlling persistent atrial fibrillation.
QJM : monthly journal of the Association of Physicians 2004;97(3):179-80.
2004: Morant S V; McMahon A D; Cleland J G F; Davey P G; MacDonald T M
Cardiovascular prophylaxis with aspirin: costs of supply and management of upper gastrointestinal and renal toxicity.
British journal of clinical pharmacology 2004;57(2):188-98.
2004: Cleland John G F; Nikitin Nikolay; McGowan James
Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
Expert review of cardiovascular therapy 2004;2(1):9-19.
2004: Cleland John G F; Freemantle Nick; Kaye Gerry; Nasir Mansoor; Velavan Periaswamy; Lalukota Krishna; Mudawi Telal; Shelton Rhidian; Clark Andrew L; Coletta Alison P
Clinical trials update from the American Heart Association meeting: Omega-3 fatty acids and arrhythmia risk in patients with an implantable defibrillator, ACTIV in CHF, VALIANT, the Hanover autologous bone marrow transplantation study, SPORTIF V, ORBIT and PAD and DEFINITE.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(1):109-15.
2004: Cleland John G F; Torp-Pedersen Christian; Coletta Alison P; Lammiman Michael J
A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2004;6(1):1-2.
2004: Banerjee Prithwish; Clark Andrew L; Cleland John G F
Diastolic heart failure: a difficult problem in the elderly.
The American journal of geriatric cardiology 2004;13(1):16-21.
2003: Ghosh J; Kaye Gerry; Cleland J G F
Cardiac resynchronization therapy with or without an implantable defibrillator: only indicated when everything else has failed?
Cardiac electrophysiology review 2003;7(4):421-9.
2003: Khand Aleem U; Rankin Andrew C; Martin William; Taylor Jacqueline; Gemmell Islay; Cleland John G F
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
Journal of the American College of Cardiology 2003;42(11):1944-51.
2003: Cleland John G F; Freemantle Nick
The CHARM programme.
Lancet 2003;362(9396):1679.
2003: Coletta Alison P; Cleland John G F; Freemantle Nick; Loh Huan; Memon Anwar; Clark Andrew L
Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(5):697-704.
2003: Louis Amala A; Turner Tracy; Gretton Marcia; Baksh Angela; Cleland John G F
A systematic review of telemonitoring for the management of heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(5):583-90.
2003: Cleland John G F; Clark Andrew L
Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth.
Journal of the American College of Cardiology 2003;42(7):1234-7.
2003: Witte K K A; Thackray S D R; Nikitin N P; Cleland J G F; Clark A L
The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure.
Heart (British Cardiac Society) 2003;89(10):1169-73.
2003: McGowan James H; Cleland John G F
Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods.
American heart journal 2003;146(3):388-97.
2003: Nikitin Nikolay P; Witte Klaus K A; Thackray Simon D R; de Silva Ramesh; Clark Andrew L; Cleland John G F
Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2003;16(9):906-21.
2003: Coletta Alison P; Clark Andrew L; Seymour Anne Marie L; Cleland John G F
Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(4):545-8.
2003: Cleland J G F; Pennell D J; Ray S G; Coats A J; Macfarlane P W; Murray G D; Mule J Dalle; Vered Z; Lahiri A;
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial.
Lancet 2003;362(9377):14-21.
2003: Poole-Wilson Philip A; Swedberg Karl; Cleland John G F; Di Lenarda Andrea; Hanrath Peter; Komajda Michel; Lubsen Jacobus; Lutiger Beatrix; Metra Marco; Remme Willem J; Torp-Pedersen Christian; Scherhag Armin; Skene Allan;
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Lancet 2003;362(9377):7-13.
2003: Cleland John G F; Freemantle Nick
Cardiac resynchronization for progressive heart failure.
JAMA : the journal of the American Medical Association 2003;290(1):36-7; author reply 37-8.
2003: Schwartz J Sanford; Wang Y Richard; Cleland John G F; Gao Longlong; Weiner Mark; Poole-Wilson Philip A;
High- versus low-dose angiotensin converting enzyme inhibitor therapy in the treatment of heart failure: an economic analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial.
The American journal of managed care 2003;9(6):417-24.
2003: Thackray Simon D R; Witte Klaus K A; Nikitin Nikolay P; Clark Andrew L; Kaye Gerald C; Cleland John G F
The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population.
European heart journal 2003;24(12):1143-52.
2003: Cleland John G F; Coletta Alison P; Nikitin Nikolay; Louis Amala; Clark Andrew
Update of clinical trials from the American College of Cardiology 2003. EPHESUS, SPORTIF-III, ASCOT, COMPANION, UK-PACE and T-wave alternans.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(3):391-8.
2003: Cleland J G F; Freemantle N; Ball S G; Bonser R S; Camici P; Chattopadhyay S; Dutka D; Eastaugh J; Hampton J; Large S; Norell M S; Pennell D J; Pepper J; Sanda S; Senior R; Smith D
The heart failure revascularisation trial (HEART): rationale, design and methodology.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(3):295-303.
2003: Witte K K A; Thackray S D R; Nikitin N P; Cleland J G F; Clark A L
Pattern of ventilation during exercise in chronic heart failure.
Heart (British Cardiac Society) 2003;89(6):610-4.
2003: Cleland J G F; Ghosh J; Khan N; Hurren S; Kaye G
Ongoing trials of cardiac resynchronisation.
Minerva cardioangiologica 2003;51(2):197-207.
2003: Cleland John G F
Beta-blockers for heart failure: why, which, when, and where.
The Medical clinics of North America 2003;87(2):339-71.
2003: Cleland J G F; Swedberg K; Follath F; Komajda M; Cohen-Solal A; Aguilar J C; Dietz R; Gavazzi A; Hobbs R; Korewicki J; Madeira H C; Moiseyev V S; Preda I; van Gilst W H; Widimsky J; Freemantle N; Eastaugh Joanne; Mason J;
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.
European heart journal 2003;24(5):442-63.
2003: Cleland John G F; Ghosh Justin; Khan Nasrin K; Ghio Stefano; Tavazzi Luigi; Kaye Gerry
Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony?
European heart journal 2003;24(5):384-90.
2003: Nikitin N P; Witte K K A; Thackray S D R; Goodge L J; Clark A L; Cleland J G F
Effect of age and sex on left atrial morphology and function.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2003;4(1):36-42.
2003: Cleland J G F; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(1):101-8.
2003: Coletta A P; Nikitin N; Clark A L; Cleland J G F
Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(1):95-9.
2003: Poole-Wilson P A; Uretsky B F; Thygesen K; Cleland J G F; Massie B M; Rydén L;
Mode of death in heart failure: findings from the ATLAS trial.
Heart (British Cardiac Society) 2003;89(1):42-8.
2002: Cleland J G F; Cohen-Solal A; Aguilar J Cosin; Dietz R; Eastaugh J; Follath F; Freemantle N; Gavazzi A; van Gilst W H; Hobbs F D R; Korewicki J; Madeira H C; Preda I; Swedberg K; Widimsky J;
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.
Lancet 2002;360(9346):1631-9.
2002: Nikitin Nikolay P; Witte Klaus K A; Clark Andrew L; Cleland John G F
Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function.
The American journal of cardiology 2002;90(10):1174-7.
2002: Coletta A P; Louis A A; Clark A L; Nikitin N; Cleland J G F;
Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN-HMS, MAGIC, SOLVD-X and PATH-CHF II.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(5):661-6.
2002: Cleland J G F
Contemporary management of heart failure in clinical practice.
Heart (British Cardiac Society) 2002;88 Suppl 2():ii5-8.
2002: Witte Klaus K A; Morice Alyn; Clark Andrew L; Cleland John G F
Airway resistance in chronic heart failure measured by impulse oscillometry.
Journal of cardiac failure 2002;8(4):225-31.
2002: Coletta A P; Clark A L; Banarjee P; Cleland J G F
Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(4):559-61.
2002: Thackray Simon; Easthaugh Joanne; Freemantle Nick; Cleland John G F
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(4):515-29.
2002: Khand A U; Cleland J G F; Deedwania P C
Prevention of and medical therapy for atrial arrhythmias in heart failure.
Heart failure reviews 2002;7(3):267-83.
2002: Cleland John G F; Chattopadhyay Sudipta; Khand Aleem; Houghton Timothy; Kaye Gerald C
Prevalence and incidence of arrhythmias and sudden death in heart failure.
Heart failure reviews 2002;7(3):229-42.
2002: Follath F; Cleland J G F; Just H; Papp J G Y; Scholz H; Peuhkurinen K; Harjola V P; Mitrovic V; Abdalla M; Sandell E-P; Lehtonen L;
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Lancet 2002;360(9328):196-202.
2002: Coletta Alison; Thackray Simon; Nikitin Nikolay; Cleland John G F
Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(3):381-8.
2002: Poole-Wilson Philip A; Cleland John G F; Di Lenarda Andrea; Hanrath Peter; Komajda Michel; Metra Marco; J Remme Willem; Swedberg Karl; Torp-Pedersen Christian
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(3):321-9.
2002: Cleland John G F
How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(3):243-7.
2002: Cleland John G F; McGowan James
Levosimendan: a new era for inodilator therapy for heart failure?
Current opinion in cardiology 2002;17(3):257-65.
2002: Cleland John G F
Chronic aspirin is effective--if data are massaged sufficiently.
BMJ (Clinical research ed.) 2002;324(7332):295.
2002: Cleland John G F
Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease.
Progress in cardiovascular diseases 2002;44(4):275-92.
2002: Cleland John G F; Thackray Simon; Goodge Lyndsey; Kaye Gerry; Cooklin Michael
Outcome studies with device therapy in patients with heart failure.
Journal of cardiovascular electrophysiology 2002;13(1 Suppl):S73-91.
2002: Louis Amala A; Manousos I Renata; Coletta Alison P; Clark Andrew L; Cleland John G F
Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2002;4(1):111-6.
2002: Cleland John G F
No reduction in cardiovascular risk with NSAIDs-including aspirin?
Lancet 2002;359(9301):92-3.
2002: Cleland John G F
Preventing atherosclerotic events with aspirin.
BMJ (Clinical research ed.) 2002;324(7329):103-5.
2002: Banerjee Prithwish; Banerjee Tumpa; Khand Aleem; Clark Andrew L; Cleland John G F
Diastolic heart failure: neglected or misdiagnosed?
Journal of the American College of Cardiology 2002;39(1):138-41.
2002: Nikitin N P; Cleland J G F
[Use of myocardial tissue Doppler imaging in cardiology]
Kardiologiia 2002;42(3):66-79.
2001: Coletta A P; Cleland J G
Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(6):747-50.
2001: McGowan J H; Martin W; Burgess M I; McCurrach G; Ray S G; McDonagh T A; Cleland J G
Validation of an echocardiographic wall motion index in heart failure due to ischaemic heart disease.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(6):731-7.
2001: Cowburn P J; Cleland J G
Endothelin antagonists for chronic heart failure: do they have a role?
European heart journal 2001;22(19):1772-84.
2001: Cleland J G; John J; Houghton T
Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure?
Current opinion in nephrology and hypertension 2001;10(5):625-31.
2001: Cleland J G; Thygesen K; Uretsky B F; Armstrong P; Horowitz J D; Massie B; Packer M; Poole-Wilson P A; Rydén L;
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study.
European heart journal 2001;22(17):1601-12.
2001: Thackray S; Coletta A; Jones P; Dunn A; Clark A L; Cleland J G
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(4):491-4.
2001: Cleland J G; Daubert J C; Erdmann E; Freemantle N; Gras D; Kappenberger L; Klein W; Tavazzi L;
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(4):481-9.
2001: Louis A; Cleland J G; Crabbe S; Ford S; Thackray S; Houghton T; Clark A
Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(3):381-7.
2001: Cleland J G; Alamgir F; Nikitin N P; Clark A L; Norell M
What is the optimal medical management of ischemic heart failure?
Progress in cardiovascular diseases 2001;43(5):433-55.
2001: Massie B M; Armstrong P W; Cleland J G; Horowitz J D; Packer M; Poole-Wilson P A; Rydén L
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.
Archives of internal medicine 2001;161(2):165-71.
2001: Thackray S D; Witte K K; Khand A; Dunn A; Clark A L; Cleland J G
Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2001;3(1):117-24.
2001: Khand A U; Gemmell I; Rankin A C; Cleland J G
Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges.
European heart journal 2001;22(2):153-64.
2001: Cleland J G; John J; Dhawan J; Clark A
What is the optimal medical management of ischaemic heart failure?
British medical bulletin 2001;59():135-58.
2000: Khand A; Gemmel I; Clark A L; Cleland J G
Is the prognosis of heart failure improving?
Journal of the American College of Cardiology 2000;36(7):2284-6.
2000: Witte K; Thackray S; Clark A L; Cooklin M; Cleland J G
Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(4):455-60.
2000: Yap J C; Moore D M; Cleland J G; Pride N B
Effect of supine posture on respiratory mechanics in chronic left ventricular failure.
American journal of respiratory and critical care medicine 2000;162(4 Pt 1):1285-91.
2000: Houghton T; Freemantle N; Cleland J G
Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(3):333-40.
2000: Bellenger N G; Burgess M I; Ray S G; Lahiri A; Coats A J; Cleland J G; Pennell D J
Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?
European heart journal 2000;21(16):1387-96.
2000: Uretsky B F; Thygesen K; Armstrong P W; Cleland J G; Horowitz J D; Massie B M; Packer M; Poole-Wilson P A; Ryden L
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.
Circulation 2000;102(6):611-6.
2000: Cleland J G; Swedberg K; Cohen-Solal A; Cosin-Aguilar J; Dietz R; Follath F; Gavazzi A; Hobbs R; Korewicki J; Madeira H C; Preda I; van Gilst W H; Widimsky J; Mareev V; Mason J; Freemantle N; Eastaugh J
The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(2):123-32.
2000: Khand A U; Rankin A C; Kaye G C; Cleland J G
Systematic review of the management of atrial fibrillation in patients with heart failure.
European heart journal 2000;21(8):614-32.
2000: Clark A L; Cleland J G
The control of adrenergic function in heart failure: therapeutic intervention.
Heart failure reviews 2000;5(1):101-14.
2000: Cleland J G; Mohacsi P; Murphy R L
Implantable left ventricular assist systems: clinical trials. The StudyGroup on Advanced Heart Failure of the Working Group on Heart Failure.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2000;2(1):19-21.
2000: Pennell D J; Ray S G; Davies G; Burgess M; Webster J; Slomka P; Atkinson P; Cleland J G
The carvedilol hibernation reversible ischaemia trial, marker of success (CHRISTMAS) study. Methodology of a randomised, placebo controlled, multicentre study of carvedilol in hibernation and heart failure.
International journal of cardiology 2000;72(3):265-74.
2000: Cleland J G; Baksh A; Louis A
Polypharmacy (or polytherapy) in the treatment of heart failure.
Heart failure monitor 2000;1(1):8-13.
1999: Dutka D P; Puri S; Strong R; Cleland J G
Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(4):371-7.
1999: Hillier C; Cowburn P J; Morton J J; Dargie H J; Cleland J G; McMurray J J; McGrath J C
Structural and functional assessment of small arteries in patients with chronic heart failure.
Clinical science (London, England : 1979) 1999;97(6):671-9.
1999: Smith A A; Cowburn P J; Parker M E; Denvir M; Puri S; Patel K R; Cleland J G
Impaired pulmonary diffusion during exercise in patients with chronic heart failure.
Circulation 1999;100(13):1406-10.
1999: Alamgir F; Caplin J L; Cleland J G; Norell M; Kaye G C
Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease.
Lancet 1999;354(9181):863; author reply 863-4.
1999: Cleland J G; Gemmell I; Khand A; Boddy A
Is the prognosis of heart failure improving?
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(3):229-41.
1999: Cleland J G; Tendera M; Adamus J; Freemantle N; Gray C S; Lye M; O'Mahony D; Polonski L; Taylor J
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 1999;1(3):211-7.
1999: Cleland J G; Swedberg K
Influence of aetiology on the effects of treatment in heart failure.
Journal of cardiovascular risk 1999;6(3):131-9.
1999: Cleland J G; McGowan J
Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression.
Journal of cardiovascular pharmacology 1999;33 Suppl 3():S17-29.
1999: Cleland J G
Causes of death in the ATLAS study: effects of high-dose ACE inhibitors.
International journal of clinical practice. Supplement 1999;100():19-20.
1999: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J; Morton J J
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.
Journal of the American College of Cardiology 1999;33(4):932-8.
1999: Cleland J G; Clark A
Has the survival of the heart failure population changed? Lessons from trials.
The American journal of cardiology 1999;83(5B):112D-119D.
1999: Puri S; Dutka D P; Baker B L; Hughes J M; Cleland J G
Acute saline infusion reduces alveolar-capillary membrane conductance and increases airflow obstruction in patients with left ventricular dysfunction.
Circulation 1999;99(9):1190-6.
1999: Cleland J G
Progression from hypertension to heart failure. Mechanisms and management.
Cardiology 1999;92 Suppl 1():10-9; discussion 20-1.
1998: Cleland J G
Health economic consequences of the pharmacological treatment of heart failure.
European heart journal 1998;19 Suppl P():P32-9.
1998: Follath F; Cleland J G; Klein W; Murphy R
Etiology and response to drug treatment in heart failure.
Journal of the American College of Cardiology 1998;32(5):1167-72.
1998: Cleland J G; Walker A
Therapeutic options and cost considerations in the treatment of ischemic heart disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1998;12 Suppl 3():225-32.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; Dargie H J; McMurray J J; Morton J J
Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.
Cardiovascular research 1998;39(3):563-70.
1998: Cleland J G; Swedberg K; Poole-Wilson P A
Successes and failures of current treatment of heart failure.
Lancet 1998;352 Suppl 1():SI19-28.
1998: Cleland J G
Heart failure: a medical hydra.
Lancet 1998;352 Suppl 1():SI1-2.
1998: Brown A M; Cleland J G
Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995.
European heart journal 1998;19(7):1063-9.
1998: Cleland J G
Are symptoms the most important target for therapy in chronic heart failure?
Progress in cardiovascular diseases 1998;41(1 Suppl 1):59-64.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J
Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure.
Lancet 1998;352(9123):201-2.
1998: McMurray J V; McDonagh T A; Davie A P; Cleland J G; Francis C M; Morrison C
Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?
European heart journal 1998;19(6):842-6.
1998: Massie B M; Cleland J G; Armstrong P W; Horowitz J D; Packer M; Poole-Wilson P A; Ryden L;
Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial Investigators.
Journal of cardiac failure 1998;4(1):3-8.
1998: Cleland J G; McGowan J; Cowburn P J
Beta-blockers for chronic heart failure: from prejudice to enlightenment.
Journal of cardiovascular pharmacology 1998;32 Suppl 1():S52-60.
1998: Cowburn P J; Cleland J G; McArthur J D; MacLean M R; McMurray J J; Dargie H J
Pulmonary and systemic responses to exogenous endothelin-1 in patients with left ventricular dysfunction.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S290-3.
1997: Cleland J G
Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11 Suppl 1():297-303.
1997: Cleland J G; Walker A
Is medical treatment for angina the most cost-effective option?
European heart journal 1997;18 Suppl B():B35-42.
1997: Cleland J G; Erhardt L; Murray G; Hall A S; Ball S G
Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
European heart journal 1997;18(1):41-51.
1996: Cleland J G; Cowburn P J; Morgan K
Neuroendocrine activation after myocardial infarction: causes and consequences.
Heart (British Cardiac Society) 1996;76(3 Suppl 3):53-9.
1996: Cleland J G; Bristow M R; Erdmann E; Remme W J; Swedberg K; Waagstein F
Beta-blocking agents in heart failure. Should they be used and how?
European heart journal 1996;17(11):1629-39.
1996: Narang R; Cleland J G; Erhardt L; Ball S G; Coats A J; Cowley A J; Dargie H J; Hall A S; Hampton J R; Poole-Wilson P A
Mode of death in chronic heart failure. A request and proposition for more accurate classification.
European heart journal 1996;17(9):1390-403.
1996: Dutka D P; Olivotto I; Ward S; Oakley C M; Impallomeni M; Cleland J G
Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction.
The American journal of cardiology 1996;77(14):1197-201.
1996: Cleland J G; Morgan K
Inhibition of the renin-angiotensin-aldosterone system in heart failure: new insights from basic clinical research.
Current opinion in cardiology 1996;11(3):252-62.
1996: Cleland J G; Cowburn P J; Falk R H
Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials.
European heart journal 1996;17(5):674-81.
1996: Cleland J G; Swedberg K
Carvedilol for heart failure, with care.
Lancet 1996;347(9010):1199-201.
1996: Cleland J G; Ward S; Dutka D; Habib F; Impallomeni M; Morton I J
Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature.
Heart (British Cardiac Society) 1996;75(4):410-3.
1996: Cleland J G
Can improved quality of care reduce the costs of managing angina pectoris?
European heart journal 1996;17 Suppl A():29-40.
1996: Jiang B Y; Habib F; Oakley C M; Cleland J G
Shortened duration of post-ischemic hyperemic blood flow in the forearm of patients with heart failure.
The American journal of cardiology 1996;77(4):300-2.
1996: Narang R; Swedberg K; Cleland J G
What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity.
European heart journal 1996;17(1):120-34.
1995: Ryan M P; Cleland J G; French J A; Joshi J; Choudhury L; Chojnowska L; Michalak E; al-Mahdawi S; Nihoyannopoulos P; Oakley C M
The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy.
The American journal of cardiology 1995;76(10):689-94.
1995: Dutka D P; Olivotto I; Ward S; Nihoyannopoulos P; al-Subaili M; Oakley C M; Impallomeni M; Cleland J G
Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure.
European heart journal 1995;16(9):1223-30.
1995: Brookes C I; Hart P; Keogh B E; Cleland J G
Angiography and the aetiology of heart failure.
Postgraduate medical journal 1995;71(838):480-2.
1995: Puri S; Baker B L; Dutka D P; Oakley C M; Hughes J M; Cleland J G
Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.
Circulation 1995;91(11):2769-74.
1995: Cleland J G
ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'?
Journal of human hypertension 1995;9(6):435-42.
1995: Good J M; Peters M; Wilkins M; Jackson N; Oakley C M; Cleland J G
Renal response to candoxatrilat in patients with heart failure.
Journal of the American College of Cardiology 1995;25(6):1273-81.
1995: Ryan M P; French J; al-Mahdawi S; Nihoyannopoulos P; Cleland J G; Oakley C M; Harper P S; Clarke A; Davis J; Grigg L
Genetic testing for familial hypertrophic cardiomyopathy in newborn infants.
BMJ (Clinical research ed.) 1995;310(6983):856-9.
1995: Cleland J G
ACE inhibitors for myocardial infarction: how should they be used?
European heart journal 1995;16(2):153-9.
1994: Good J M; Nihoyannopoulos P; Ghatei M A; Crossman D; Bloom S R; Clark P; Oakley C M; Cleland J G
Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?
European heart journal 1994;15(12):1634-40.
1994: Cleland J G; Puri S
How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
British heart journal 1994;72(3 Suppl):S81-6.
1994: Cleland J G
ACE inhibitors: current understanding and future directions.
British heart journal 1994;72(3 Suppl):S1.
1994: Cleland J G; Dutka D P
Optimising heart failure pharmacotherapy: the ideal combination.
British heart journal 1994;72(2 Suppl):S73-9.
1994: Puri S; Baker B L; Oakley C M; Hughes J M; Cleland J G
Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure.
British heart journal 1994;72(2):140-4.
1994: Habib F; Dutka D; Crossman D; Oakley C M; Cleland J G
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
Lancet 1994;344(8919):371-3.
1994: Morgan K; Wharton J; Webb J C; Keogh B E; Smith P L; Taylor K M; Oakley C M; Polak J M; Cleland J G
Co-expression of renin-angiotensin system component genes in human atrial tissue.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(4):S11-9.
1994: Sbarouni E; Bradshaw A; Andreotti F; Tuddenham E; Oakley C M; Cleland J G
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.
American heart journal 1994;127(3):607-12.
1994: Cleland J G
The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.
European heart journal 1994;15(1):125-30.
1993: Cleland J G; Shah D; Krikler S; Dritsas A; Nihoyannopoulos P; Frost G; Oakley C M
Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.
British heart journal 1993;69(6):512-5.
1993: Cleland J G; Krikler D M
Modification of atherosclerosis by agents that do not lower cholesterol.
British heart journal 1993;69(1 Suppl):S54-62.
1993: Cleland J G; Erhardt L; Hall A S; Winter C; Ball S G
Validation of primary and secondary outcomes and classification of mode of death among patients with clinical evidence of heart failure after a myocardial infarction: a report from the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.
Journal of cardiovascular pharmacology 1993;22 Suppl 9():S22-7.
1992: Cleland J G; Shah D; Krikler S; Frost G; Oakley C M
Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure.
The American journal of cardiology 1992;70(10):55C-61C.
1992: Cleland J G
Ancillary diagnostic and therapeutic issues in cardiac failure.
Current opinion in cardiology 1992;7(3):408-15.
1992: Cleland J G
Angiotensin converting enzyme inhibitors for hypertension and heart failure?
Postgraduate medical journal 1992;68(795):1-5.
1992: Good J; Frost G; Oakley C M; Cleland J G
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Postgraduate medical journal 1992;68 Suppl 2():S7-11.
1991: Cleland J G; Oakley C M
Vascular tone in heart failure: the neuroendocrine-therapeutic interface.
British heart journal 1991;66(4):264-7.
1991: Cleland J G; Henderson E; McLenachan J; Findlay I N; Dargie H J
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.
Journal of the American College of Cardiology 1991;17(3):733-9.
1990: Ang E L; Chan W L; Cleland J G; Moore D; Krikler S J; Alexander N D; Oakley C M
Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
British heart journal 1990;64(4):256-60.
1990: Cleland J G
ACE inhibitors in mild heart failure: first-line or second-line therapy?
European heart journal 1990;11 Suppl D():53-7.

Sign-in to see more